News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
525,808 Results
Type
Article (17311)
Company Profile (182)
Press Release (508554)
Multimedia
Podcasts (14)
Webinars (7)
Section
Business (176087)
Career Advice (404)
Deals (26789)
Drug Delivery (26)
Drug Development (58188)
Employer Resources (27)
FDA (10635)
Job Trends (9517)
News (253304)
Policy (19589)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1110)
Accelerated approval (34)
ADA (26)
Adcomms (6)
Allergies (102)
Alliances (36199)
ALS (155)
Alzheimer's disease (1197)
Antibody-drug conjugate (ADC) (315)
Approvals (11249)
Artificial intelligence (407)
ASCO (180)
Autoimmune disease (236)
Automation (33)
Bankruptcy (274)
Belgium (1)
Best Places to Work (7743)
BIO (44)
Biologics (10)
BIOSECURE Act (3)
Biosimilars (120)
BioSpace Insights (28)
Biotechnology (127)
Bispecific (1)
Bladder cancer (142)
Brain cancer (54)
Breast cancer (550)
Cancer (4171)
Cardiovascular disease (296)
Career advice (344)
Career pathing (3)
CAR-T (236)
CDC (2)
CDMO (45)
Celiac Disease (2)
Cell therapy (645)
Cervical cancer (36)
Clinical research (52033)
Collaboration (1525)
Commercialization (5)
Company closure (2)
Compensation (1561)
Complete response letters (46)
COVID-19 (1103)
CRISPR (99)
C-suite (894)
Cystic fibrosis (148)
Data (6571)
Denatured (5)
Depression (111)
Dermatology (74)
Diabetes (402)
Diagnostics (4979)
Digital health (40)
Diversity (3)
Diversity, equity & inclusion (12)
Drug discovery (211)
Drug pricing (12)
Drug shortages (3)
Duchenne muscular dystrophy (239)
Earnings (75487)
Editorial (12)
Employer branding (4)
Employer resources (26)
Events (93161)
Executive appointments (778)
FDA (13627)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (21)
Frontotemporal dementia (31)
Funding (1137)
Gene editing (221)
Generative AI (15)
Gene therapy (609)
GLP-1 (389)
Government (1354)
Grass and pollen (3)
Guidances (296)
Healthcare (10649)
Hematology (115)
HIV (66)
Huntington's disease (47)
IgA nephropathy (79)
Immunology and inflammation (129)
Immuno-oncology (65)
Indications (175)
Infectious disease (1318)
Inflammatory bowel disease (147)
Inflation Reduction Act (5)
Influenza (87)
Intellectual property (270)
Interviews (55)
IPO (12827)
IRA (3)
Job creations (2183)
Job search strategy (327)
JPM (8)
Kidney cancer (16)
Labor market (8)
Layoffs (127)
Legal (5423)
Licensing (18)
Liver cancer (51)
Longevity (24)
Lung cancer (587)
Lymphoma (304)
Machine learning (37)
Management (4)
Manufacturing (642)
Marketing (9)
MASH (129)
Medical affairs (2)
Medical device (8845)
Medtech (9007)
Mergers & acquisitions (15059)
Metabolic disorders (881)
mRNA (121)
Multiple sclerosis (112)
NASH (5)
Neurodegenerative disease (313)
Neuropsychiatric disorders (48)
Neuroscience (2291)
NextGen: Class of 2026 (3641)
Non-profit (1569)
Now hiring (11)
Obesity (314)
Opinion (64)
Ovarian cancer (171)
Pain (190)
Pancreatic cancer (233)
Parkinson's disease (254)
Partnered (16)
Patents (524)
Patient recruitment (600)
Patient selection (2)
Peanut (32)
People (44364)
Peptides (2)
Pharmaceutical (31)
Pharmacy benefit managers (10)
Phase 1 (17091)
Phase 2 (23220)
Phase 3 (15868)
Pipeline (8364)
Policy (40)
Postmarket research (1694)
Preclinical (7383)
Press Release (45)
Prostate cancer (205)
Psychedelics (11)
Radiopharmaceuticals (201)
Rare diseases (1000)
Real estate (3392)
Recruiting (8)
Regenerative medicine (2)
Regulatory (16549)
Reports (26)
Research institute (1299)
Resumes & cover letters (55)
Rett syndrome (51)
RNA editing (19)
RSV (50)
Schizophrenia (111)
Series A (191)
Series B (155)
Service/supplier (6)
Sickle cell disease (94)
Special edition (3)
Spinal muscular atrophy (161)
Sponsored (11)
Startups (2435)
Stomach cancer (3)
Supply chain (54)
Tariffs (3)
The Weekly (8)
Vaccines (423)
Venture capital (33)
Weight loss (118)
Women's health (96)
Date
Today (80)
Last 7 days (348)
Last 30 days (1555)
Last 365 days (20984)
2026 (14940)
2025 (21119)
2024 (25157)
2023 (28872)
2022 (37462)
2021 (40153)
2020 (36291)
2019 (26269)
2018 (19724)
2017 (20856)
2016 (20036)
2015 (26305)
2014 (23141)
2013 (19516)
2012 (21449)
2011 (21732)
2010 (21406)
Location
Africa (325)
Alabama (80)
Alaska (4)
Arizona (319)
Arkansas (12)
Asia (20679)
Australia (2715)
California (13015)
Canada (3363)
China (660)
Colorado (510)
Connecticut (470)
Delaware (224)
Europe (33501)
Florida (1893)
Georgia (404)
Hawaii (3)
Idaho (48)
Illinois (770)
India (56)
Indiana (507)
Iowa (19)
Japan (472)
Kansas (105)
Kentucky (37)
Louisiana (35)
Maine (31)
Maryland (1340)
Massachusetts (8818)
Michigan (317)
Minnesota (581)
Mississippi (5)
Missouri (88)
Montana (20)
Nebraska (15)
Nevada (123)
New Hampshire (61)
New Jersey (2788)
New Mexico (14)
New York (3048)
North Carolina (1393)
North Dakota (7)
Northern California (6602)
Ohio (334)
Oklahoma (14)
Oregon (21)
Pennsylvania (2415)
Puerto Rico (22)
Rhode Island (37)
South America (504)
South Carolina (78)
South Dakota (1)
Southern California (5312)
Tennessee (132)
Texas (2083)
United States (42622)
Utah (384)
Vermont (1)
Virginia (191)
Washington D.C. (44)
Washington State (1160)
West Virginia (2)
Wisconsin (85)
Wyoming (1)
525,808 Results for "seattle genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
Press Releases
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
August 24, 2026
·
5 min read
Press Releases
Genethon’s Recent Accomplishments Underscore the Progress of Genetic Medicine from Scientific Promise to Clinical Reality
July 13, 2026
·
2 min read
Press Releases
Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial
September 16, 2026
·
2 min read
Press Releases
Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing
July 27, 2026
·
4 min read
Press Releases
Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference
August 27, 2026
·
1 min read
Press Releases
Myriad Genetics Launches FirstGene® Multiple Prenatal Screen
July 21, 2026
·
5 min read
ALS
QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS
Biogen’s Qalsody won FDA approval in 2023 to treat a rare, genetic form of amyotrophic lateral sclerosis. On Tuesday, QurAlis presented interim Phase 2 data showing the potential of a similar drug to more broadly treat the neurodegenerative disease.
May 5, 2026
·
4 min read
·
Heather McKenzie
Manufacturing
Lilly invests $4.5B in Indiana manufacturing, opens doors of 1st genetic medicine site
Eli Lilly’s latest manufacturing expansion will support production of obesity blockbusters and next-gen assets, while the new Lilly Lebanon Advanced Therapies site will take experimental genetic medicines from research to commercialization.
May 8, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
August 6, 2026
·
10 min read
1 of 52,581
Next
